Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Fully humanized antibody for diagnosis and therapy of cancer

Oct. 10, 2001

Lorus and Faulding establish Virulizin distribution agreement for Latin America

Oct. 10, 2001

FDA grants orphan drug designation to Celgene's Revimid for multiple myeloma

Oct. 9, 2001

Campath trial for T-PLL yields promising results

Oct. 2, 2001

Pharmexa cleared to begin phase I/II breast cancer trial in the U.K.

Sep. 28, 2001

New DNA vaccine provides both tumor-specific immunity and antiangiogenesis

Sep. 25, 2001

Allovectin-7 phase III registration trial in metastatic melanoma now fully enrolled

Sep. 20, 2001

Rituximab now available in Japan

Sep. 14, 2001

NeoPharm seeks orphan drug status for IL-13-PE38

Sep. 14, 2001

Provenge advances towards 2002 BLA submission

Sep. 13, 2001

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.